Source / episode info
- **Episode:**319
- **Title:**Divine Intervention Episode 319 – NBME Gastroenterology Series 6 (for all USMLEs).
- **Published:**2021-06-08
- Source:Episode page
One-liner
This episode provides deep pathophysiology reviews of five major cholestatic liver disorders: PBC, PSC, hemochromatosis, Wilson's disease, and _1-ATD, emphasizing unique diagnostic markers, metabolic pathways, and organ deposition patterns.
High-yield summary
- PBC: Characterized by anti-mitochondrial antibodies (AMA), affects the intra-lobular bile ducts, and is typically seen in middle-aged women with direct hyperbilirubinemia. Treatment involves Ursodiol (UDCA); liver transplant is curative.
- PSC: Associated with a history of inflammatory bowel disease (especially UC) and leads to strictures affecting both the intra and extra-hepatic bile ducts. It tends to occur more frequently in men than PBC.
- Hemochromatosis: An iron overload disorder, often due to mutations in the HFE gene (C282Y, H63D). Labs show high ferritin/iron stores, low Total Iron Binding Capacity (TIBC), and high Transferrin Saturation (TSAT%). Complications include bronze diabetes and restrictive cardiomyopathy.
- Wilson's Disease: An autosomal recessive copper metabolism disorder caused by a transporter defect. Key findings include low serum ceruloplasmin, Kayser-Fleischer rings, and deposition of copper in the basal ganglia (e.g., subthalamic nucleus). Treatment involves chelating agents (Penicillamine or Zinc acetate).
- _1-ATD: An autosomal dominant disorder where defective _1-AT accumulates in the endoplasmic reticulum (ER) of hepatocytes, triggering an Unfolded Protein Response (UPR), leading to cirrhosis and emphysema.
Learning objectives
- Differentiate the pathophysiology and clinical presentation of PBC, PSC, Wilson's disease, hemochromatosis, and \alpha_1-ATD.
- Interpret iron and copper metabolism lab abnormalities in chronic liver disease.
- Understand the mechanism by which protein accumulation (e.g., \alpha_1-AT) causes hepatocyte injury via ER stress.
- Recognize the specific ductal involvement patterns of PBC vs PSC.
- Identify appropriate chelating agents or treatments for metabolic liver disorders.
Board exam buzzwords